1-N-(4-Sulfamoylphenyl-ethyl)-2,4,6-trimethylpyridinium

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-N-(4-Sulfamoylphenyl-ethyl)-2,4,6-trimethylpyridinium
• 英文别名: 4-[2-(2,4,6-trimethylpyridin-1-ium-1-yl)ethyl]benzenesulfonamide
• 化学式: C16H21N2O2S+
• 分子量: 305.4
• InChiKey: UXBCHTZINZNVRG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  72.4
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS
  申请人：CAMP4 THERAPEUTICS CORPORATION

  公开号：US20210254056A1

  公开（公告）日：2021-08-19

  The present invention provides methods and compositions for the evaluation, alteration and/or optimization of gene signaling. Methods and systems are also provided which exploit the information generated in the identification of new targets and non-canonical signaling pathways.
• [EN] COMPOSITIONS AND METHODS FOR TREATING ALCOHOL USE DISORDER OR A RELATED CONDITION THEREOF<br/>[FR] COMPOSITIONS ET PROCÉDÉS DE TRAITEMENT DE TROUBLE D'UTILISATION D'ALCOOL OU DE PATHOLOGIE ASSOCIÉE DUDIT TROUBLE
  申请人：UNIV INDIANA TRUSTEES

  公开号：WO2021087258A1

  公开（公告）日：2021-05-06

  Various aspects and embodiments disclosed herein relate generally to treating an alcohol use disorder or neuroadaptations. Embodiments include compositions and methods for modelling, treatment, reducing resistance to the treatment, prevention, and diagnosis of a condition/disease associated with alcohol use disorders, or a related clinical condition thereof. Other embodiments include methods and compositions for reducing the effects of adolescent alcohol drinking.